NASDAQ:KZR   Kezar Life Sciences, Inc.
after a lateral phase of a couple of months, try a breakout to resume a bullish direction with a target of around 1.20, otherwise if it fails it could quickly return to 092 and then 080

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。